These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13023513)

  • 21. [Specificity of absorption and excretion of chloramphenicol in premature and newborn infants].
    Ura S
    Nihon Shonika Gakkai Zasshi; 1968 May; 72(5):697-705. PubMed ID: 5748795
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical pharmacokinetics of chloramphenicol and chloramphenicol succinate.
    Ambrose PJ
    Clin Pharmacokinet; 1984; 9(3):222-38. PubMed ID: 6375931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The influence of pharmaceutical and physico-chemical factors of drugs on the result of clinical trials: chloramphenicol palmitate].
    van Oudtshoorn MC; Potgieter FJ; Koeleman HA; Pantonowitz LD
    S Afr Med J; 1969 Nov; 43(45):1375-6. PubMed ID: 4902056
    [No Abstract]   [Full Text] [Related]  

  • 24. [Absorption and excretion of drugs. V. Determination of chloramphenicol in urine and its metabolic rate].
    KAKEMI K; ARITA T; OHASHI S
    Yakugaku Zasshi; 1962 Mar; 82():345-8. PubMed ID: 14453187
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum levels of chloramphenicol in children, rhesus monkeys, and cats after administration of chloramphenicol palmitate suspension.
    Banerjee S; Bandyopadhyay A; Bhattacharjee RC; Mukherjee AK; Halder AK
    J Pharm Sci; 1971 Jan; 60(1):153-5. PubMed ID: 4994065
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate.
    Aguiar AJ; Krc J; Kinkel AW; Samyn JC
    J Pharm Sci; 1967 Jul; 56(7):847-53. PubMed ID: 6034828
    [No Abstract]   [Full Text] [Related]  

  • 27. Plasma levels and urinary excretion of thiamphenicol in premature and full-term newborn infants.
    Albores JM; Cammarota HE; Cosin JM; Gandolfi AF; Casares MS; Senet OJ; Correa de Araujo E
    Postgrad Med J; 1974 Oct; 50 Suppl 5():46-7. PubMed ID: 4470819
    [No Abstract]   [Full Text] [Related]  

  • 28. The monitoring of serum chloramphenicol levels in children with severe infections.
    Ekblad H; Ruuskanen O; Lindberg R; Iisalo E
    J Antimicrob Chemother; 1985 Apr; 15(4):489-94. PubMed ID: 4008381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An evaluation of the absorption characteristics of different chloramphenicol preparations in normal human subjects.
    Glazko AJ; Kinkel AW; Alegnani WC; Holmes EL
    Clin Pharmacol Ther; 1968; 9(4):472-83. PubMed ID: 5655479
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparative studies of chloramphenicol activity, fate and absorption in different suspensions.
    Galal EE; Raggal MH; Kamel HH; Sabbagh H; Mahmoud MA; Azzam AB
    J Egypt Med Assoc; 1965; 48():Suppl:89-97. PubMed ID: 5873680
    [No Abstract]   [Full Text] [Related]  

  • 31. Assays for chloramphenicol compared: radioenzymatic, gas chromatographic with electron capture, and gas chromatographic-mass spectrometric.
    Pickering LK; Hoecker JL; Kramer WG; Liehr JG; Caprioli RM
    Clin Chem; 1979 Feb; 25(2):300-5. PubMed ID: 759024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chloramphenicol sodium succinate kinetics in critically ill patients.
    Slaughter RL; Pieper JA; Cerra B; Brodsky B; Koup JR
    Clin Pharmacol Ther; 1980 Jul; 28(1):69-77. PubMed ID: 7389257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous measurement of chloramphenicol and chloramphenicol succinate by high-performance liquid chromatography.
    Aravind MK; Miceli JN; Kauffman RE; Strebel LE; Done AK
    J Chromatogr; 1980 Nov; 221(1):176-81. PubMed ID: 7451621
    [No Abstract]   [Full Text] [Related]  

  • 34. Blood level studies in dogs following the administration of chloromycetin.
    EADS FE; GLAZKO AJ; WOLF LM; EHRLICH J; GALBRAITH M
    Am J Vet Res; 1952 Apr; 13(47):204-6. PubMed ID: 14924143
    [No Abstract]   [Full Text] [Related]  

  • 35. The effects of functional adaptation of residual nephrons on the urinary excretion of drugs.
    Schück O; Nádvorníková H; Grafnetterová J; Prát V
    Yale J Biol Med; 1978; 51(3):351-4. PubMed ID: 735157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of chloramphenicol palmitate in neonates.
    Shankaran S; Kauffman RE
    J Pediatr; 1984 Jul; 105(1):113-6. PubMed ID: 6737126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excretion of chloramphenicol and its metabolites by the chronically diseased kidney (with respect to the theory of adaptive nephrons).
    Schück O; Prát V; Grafnetterová J; Kotanová E; Reitschlägerová V; David I
    Int J Clin Pharmacol; 1974 Jul; 10(1):33-43. PubMed ID: 4851956
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of chloramphenicol metabolites and some factors affecting metabolic disposition.
    Glazko AJ
    Antimicrob Agents Chemother (Bethesda); 1966; 6():655-65. PubMed ID: 5985304
    [No Abstract]   [Full Text] [Related]  

  • 39. Distribution of chloramphenicol to tissues, plasma and urine in pigs after oral intake of low doses.
    Aspenström-Fagerlund B; Nordkvist E; Törnkvist A; Wallgren P; Hoogenboom R; Berendsen B; Granelli K
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2016 Sep; 33(9):1411-20. PubMed ID: 27385382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relative bioavailability of intravenous chloramphenicol succinate and oral chloramphenicol palmitate in infants and children.
    Kauffman RE; Thirumoorthi MC; Buckley JA; Aravind MK; Dajani AS
    J Pediatr; 1981 Dec; 99(6):963-7. PubMed ID: 7310593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.